Public Company News & Press Release Distribution

Public Company News

APAC
Global

Everest Medicines Enters into an MOU for Partnership with China Resources Pharmaceutical Group for its mRNA Vaccine Business

China Resources Pharmaceutical Group ("CR Pharma") intends to make strategic equity investment for Everest's mRNA technology platform Partnership with CR Pharma will provide local support to navigate China regulatory pathways across mRNA vaccine platform, first in the advancement of Everest's po...

2022-04-07 07:30 5454

Denali Capital Acquisition Corp. Announces Pricing of $75 Million Initial Public Offering

NEW YORK, April 6, 2022 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA, the "Company") announced today that it priced its initial public offering ("IPO") of 7,500,000 units at a price of$10.00 per unit. The units have been approved for listing on The NASDAQ Global Market ("NASDAQ"...

2022-04-07 04:41 3979

Sharing Economy and Hanking Fof Investment Signed US$30 Million Investment Cooperation Agreement

HONG KONG, April 6, 2022 /PRNewswire/ -- Sharing Economy International Inc. ("SEII") (OTCQB: SEII), announced today that it has signed an Investment Cooperation Agreement with Hanking Fof Investment, L.P. ("Hanking"). Pursuant to the Agreement, Hanking intends to make strategic investments in SE...

2022-04-06 23:08 5534

HitGen and UPPTHERA Extend PROTAC Research Collaboration after Hit Finding Success on Undruggable Targets

CHENGDU, China, April 6, 2022 /PRNewswire/ -- HitGen Inc. ("HitGen"), a Shanghai Stock Exchange STAR-listed company (ticker code 688222.SH), today announced that the company has successfully completed the multiple-target drug discovery research projects with UPPTHERA, a Korean pharmaceutical comp...

2022-04-06 22:30 3045

Nexteer Named a General Motors Supplier of the Year Winner for Third Consecutive Year

AUBURN HILLS, Mich., April 6, 2022 /PRNewswire/ -- Nexteer Automotive, a leader in intuitive motion control, was named a 2021 General Motors Supplier of the Year winner at GM's 30th annual Supplier of the Year awards ceremony. GM's Supplier of the Year award recognizes global suppliers that dis...

2022-04-06 21:36 5101

Noah Holdings Limited Files FY2021 Annual Report On Form 20-F

SHANGHAI, April 6, 2022 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH), a leading and pioneer wealth management service provider inChina offering comprehensive one-stop advisory services on global investment and asset allocation primarily for high net worth investors...

2022-04-06 21:27 4596

China Jo-Jo Drugstores, Inc. Announces 1-for-12 Reverse Stock Split

HANGZHOU, China, April 6, 2022 /PRNewswire/ – China Jo-Jo Drugstores, Inc. (" Jo-Jo Drugstores" or the "Company") (Nasdaq: CJJD), a Cayman Islands company, reported that it expects to implement a 1-for-12 reverse stock split on its ordinary shares effectiveThursday, April 7, 2022, with trading to ...

2022-04-06 21:15 4210

Caravelle Group Co., Ltd, an Ocean Technology and Shipping Company, to Become Publicly Traded via Merger with Pacifico Acquisition Corp.

* Caravelle Group Co., Ltd ("Caravelle") is an ocean technology company providing international shipping services and carbon-neutral solutions for wood desiccation. * Caravelle has developed and commercialized its CO-Tech solution, a novel approach toward shipping time, space, and the repurpo...

2022-04-06 21:00 4162

ZEISS to Unveil Clinical Insights Supporting the Value of New Data-Driven Digital Workflow Solutions and Software Applications

Advancing ophthalmic care through integrated clinical workflow solutions: * Efficiency in the cataract workflow * Can help increase treatment outcome predictability in the corneal refractive workflow * Machine learning and artificial intelligence in the retina clinic JENA, Germany and DUBLI...

2022-04-06 21:00 2979

Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark

* Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu * Assay result of Seegene's decades-long know-how, applies DPO∙TOCE∙MuDT technologies * "Optimal solution for safe return to normalcy as distancing restrictions eased" SEOUL, South Korea, April 6...

2022-04-06 20:08 3007

Antengene's Pivotal "MARCH" Study to Evaluate Selinexor (ATG-010) in Relapsed or Refractory Multiple Myeloma Published in BMC Medicine

- Results showed an overall response rate (ORR) of 29.3% for all treated patients. - Consistent responses across all risk groups, including patients who received prior "triple-class" and CAR-T therapies or having cytogenetic abnormalities. - Selinexor is on track for a Q2:22 launch in China. SHAN...

2022-04-06 20:03 4741

Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process

AUSTIN, Texas, April 6, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced the appointment ofSharon Ballesteros as U.S Head of Quality and Development Process. Sharon has over 20 years of experience within the in vitro d...

2022-04-06 20:00 4120

Quantum Solutions and FOMM to Manufacture First Electric Vehicle for the Japan Market Since Establishing Joint Venture

HONG KONG, April 6, 2022 /PRNewswire/ -- Quantum Solutions (Quantum), the only independent electric vehicle (EV) company listed inJapan, announced that a major shareholder has granted a400-million-yen loan to begin production of its first EV model with its joint-venture partner. This is a crucia...

2022-04-06 17:34 4534

Ascletis Announces China IND Approval of Its Second FASN Inhibitor ASC60 for Treatment of Advanced Solid Tumors

HANGZHOU, China and SHAOXING, China, April 6, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that the Investigational New Drug (IND) application of its second fatty acid synthase (FASN) inhibitor ASC60 for treatment of advanced solid tumors has been approved by China ...

2022-04-06 17:10 5093

Jianpu Technology Inc. to Report Second Six Months and Fiscal Year 2021 Financial Results on Tuesday, April 12, 2022

BEIJING, April 6, 2022 /PRNewswire/ -- Jianpu Technology Inc. ("Jianpu," or the "Company") (NYSE: JT), a leading independent open platform for discovery and recommendation of financial products inChina, today announced that it will report its second six months and fiscal year 2021 unaudited finan...

2022-04-06 17:00 3692

Harbour BioMed Announces Poster Presentation on the Novel Bispecific Antibody PD-L1xCD40 at Upcoming American Association for Cancer Research (AACR) Annual Meeting

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, April 6, 2022 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, today announced that the poster presenta...

2022-04-06 15:04 3214

Pintec Empowers Wagepay to Upgrade Digital Credit Services

MELBOURNE, Australia, April 6, 2022 /PRNewswire/ -- Pintec Technology Holdings Limited ("Pintec"; NASDAQ: PT), a leading provider of financial technology solutions, today announced that its partner Wagepay Pty. Ltd. (Wagepay), an Australian Pay-on-Demand service provider, has recently launched it...

2022-04-06 13:11 6088

PSMA-PET Imaging to be Funded through Medicare in Australia from July 2022

MELBOURNE, Australia, April 6, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) welcomes the listing of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) (PSMA-PET) imaging for patients with prostate cancer on the Medicare Benefits Sche...

2022-04-06 12:47 4093

Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma with A FGFR2 Fusion or Rearrangement As Confirmed By A Validated Diagnostic Test That Have Progressed After at Least One Prior Line of Systemic Therapy

SAN FRANCISCO and SUZHOU, China, April 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2022-04-06 12:43 4680

CIMC generates $25.7 billion in operating revenue, marking the fastest y-o-y growth in nearly 10 years

SHENZHEN, China, April 5, 2022 /PRNewswire/ -- Chinese leading logistics and energy equipment supplier China International Marine Containers (Group) Ltd posted approximately163.7 billion yuan ($25.7 billion) in operating revenue in 2021, a 74-percent growth year-on-year, marking the first time fo...

2022-04-06 10:11 4349

1 ... 1508 1509 151015111512 1513 1514 ... 1649